During a reception in Hanoi on October 15 for Founder and Chief Technology Officer of NG Biotech Company Milovan Stankov, Hue affirmed that the Vietnamese Party and State always consider public health care as a top priority.
He welcomed the cooperation between NG Biotech and Vietnamese firms to facilitate the transfer of SARS-CoV-2 testing kit production technology.
Congratulating a joint venture between NG Biotech and Vietnam’s Vingroup on its readiness to produce SARS-CoV-2 testing kits, Hue expressed his hope that NG Biotech and T&T Group will work closely together as scheduled to manufacture more products for prevention and control of communicable diseases such as tuberculosis, hepatitis B and other tropical diseases.
The Vietnamese National Assembly and Government are striving to fine-tune institutions, including the Law on Medical Examination and Treatment and the Law on Prevention and Control of Infectious Diseases, he said.
He added that Vietnam has paid due attention to improving its business climate and offering all possible support to domestic firms and attracting foreign direct investment, with priority given to health care and education.
On the occasion, the top legislator also thanked NG Biotech for its donation of 1 million rapid antigen testing kits to Vietnam in September.
Stankov, for his part, said he wants to share scientific knowledge and technologies in the field of production, development and distribution of biological products, medicines, quality testing devices, including rapid SARS-CoV-2 testing kits, to help Vietnam improve its capacity of fighting COVID-19 and other diseases.
He also expressed his readiness to learn about Vietnamese people’s demand for health check-up and treatment to produce suitable medical products.
